Support For Those Quitting Prolia
I wanted to start this Discussion as a support thread for those who have already decided to quit Prolia and are in the process of transitioning out of Prolia to share our knowledge, thoughts, decisions and experiences as i had difficulty finding such posts from the various other Prolia threads. Those who have already completed their transition from Prolia are most welcome to contribute their experience.
It would help if you could include some basic info such as TScores, BTMs if available, number of Prolia injections taken, what med you transitioned to, length of time on relay drug and any feedback on effectiveness/reaction to the relay drug.
To prevent overlap with other Discussions already on this forum, the reasons for quitting Prolia need not be raised and it will be assumed that you have already done your research and made your decision. It is hoped that this Discussion will focus more on any feedback/advice that can assist in the transitioning process i.e. not on the 'Why' (quit Prolia) but more on the 'How' (to manage the transition).
Maybe i can start.
Background:
My TScores from my 1st DXA scan in May 2022 were:
Lumbar Spine -1.3
Femoral Neck -2.7
Total Hip -3.0
Unfortunately, my PCP did not order any BTMs so i do not have any baseline numbers.
My 1st Prolia shot was in July 2022, 2nd in Jan 2023 and my 3rd in July 2023.
In Dec 2023 after 18 months on Prolia, i did my 2nd DXA and the results were:
Lumbar Spine -1.1
Femoral Neck -2.6
I decided to quit Prolia before the 4th shot and started on weekly Alendronate in Jan 2024. To date, i have taken 7 Alendronate tablets.
Feedback on Alendronate:
The relay drugs most often cited are Reclast (most frequent) and Alendronate. Alendronate is not recommended for those with esophagus issues as it can irritate and damage the digestive tract.
I decided on Alendronate instead of Reclast as i was wary of taking in a full 1 year's dose of meds in one go and also because i read that the timing of the Reclast infusion can be tricky and the wrong timing may necessitate additional infusions. With Alendronate being a smaller weekly dose, the timing is not really an issue provided there is no delay in starting it at the time the Prolia shot is due.
The 2 days after the first Alendronate tablet and also after the 3rd tablet, i had a bit of stomach pain which went away after i took Veragel. From the 4th week to the 7th week, i have had an achy feeling at the side of my left knee. More surprisingly, i had 3 episodes of tinnitus after my 6th tablet, something which i have not experienced for a long time.
All the above side-effects have been bearable so i will continue with the Alendronate. I pray for the side-effects to cease as i do not want to go on Reclast and i read that Actonel is not potent enough to mitigate the rebound effect.
I plan to do a BTM test in Mar 2024 and quarterly thereafter for the 1st year and a DXA at the end of the 1st year. Depending on the results, i may stop the Alendronate or perhaps go on half-dosage for another 6 months instead of stopping cold turkey. Will also do a BTM at 18 months and a BTM cum DXA at 24 months of Alendronate as the rebound window supposedly stretches over 30 months from the last Prolia shot.
Interested in more discussions like this? Go to the Osteoporosis & Bone Health Support Group.
Hi formisc,
Thanks for the complement on the video. I worked for Intel for 20 years and gave a lot of PowerPoint presentations so making it was a lot of fun. And thanks for the response to my post. I think people learn the most from open discussion.
A comment on the Cleveland Clinic video with Dr. Chad Deal. He makes the comment that “so when denosumab is started, I always remind the patient that it’s forever” is absolutely not true and irresponsible based on experts like Dr. John Bilezikian, Dr. Michael McClung (whose study he references), Dr. Serge Ferrari, as well as the studies he references later in his own presentation. Those studies show a rebound effect that lasts for about a year and can be mitigated by taking either Alendronate or ReClast or both. Yes, you will lose about 5% or ½ T-score in that year period for long term denosumab users, but you can gain multiple T-scores being on denosumab. I show some of these studies in my presentation. And to be clear on some of the other points he makes about fractures after stopping denosumab, those are only prevalent is you do not follow with a bisphosphonate. I show some of that in my presentation with details I did not talk to in the backup.
From the trainings I have attended, antiresorptive risk of ONJ or atypical fractures is well below the risk of a major osteoporotic fracture of not taking them, even long term. I have not heard one doctor argue against this point.
I have no idea on insurance coverage of Prolia but I could see that as an issue. If you stop Prolia too early, you are not left with many options to maintain your bone density for the rest of your life.
Prolia has its place, and in my mind, is almost never the first treatment for osteoporosis. But for some people, like myself, Evenity did not get me to a point that a bisphosphonate would get me out of the osteoporosis range. Prolia is the only option left and I will be on it for 10+ years to get there.
Like you, I’m not a doctor. That said, I’m an engineer looking at a whole bunch of data. And agree, I too am just providing my viewpoint so others can work with their doctor for the best treatment plan for them.
Hi Michael,
Thank you for your quick response.
Much as i disagee with many of your viewpoints, i secretly hope that you are right because, having taken 3 Prolia shots and now transitioning onto Alendronate, i am worried sick about the possibility of MVFs.
Each person will have to decide, based on advice from his/her doctor and more importantly, based on his/her own research on the appropriate treatment for this disease. Personally, i do not want to use a drug that does nothing to stimulate growth of new bone but merely coats over existing old bones especially with all the unique risks that it brings along but i acknowledge that there may be cases where such use may be appropriate.
I have not written off science and i hope that in the near future, we will have effective medicines that can treat this condition safely
@michaellavacot this sentence confused me:
"But for some people, like myself, Evenity did not get me to a point that a bisphosphonate would get me out of the osteoporosis range."
Did you mean Prolia not bisphosphonate?
How did you determine that the doctors you reference are the 'top doctors in osteroporosis.' There are a lot of players in this particular game including many who call themselves 'doctors' but are not licensed medical practitioners.
What is a 'significant risk' of fracture or osteonecrosis?" And how does this risk compare to the risk of fracture without treatment? Numbers would be helpful here, if possible.
About the 'rebound period.' You say that the studies you reviewed show a rebound period of 1 year. In the original post initiating this thread, the rebound period is referenced as 30 months.
That is a significant difference. Would be helpful to know which one is more generally recognized and the source of/authority for that info.
This is an amazing discussion. Thank you.
This is exactly the summary I imagined the Amgen drug representative provided to my doctor at his office or the marketing presentations at doctor conferences Amgen sponsors at exotic resorts.
As I retired person, I hate the thought of all the time it will take to wade through the original source material. Would much rather contemplate the migratory patterns of the monarch butterfly,
Hi Formisc,
I understand your viewpoint with so much data being thrown around. I was in your camp for some time before I decided to get the latest information from the doctors that are training doctors at the major osteoporosis conventions. The grand daddy of these events is the World Congress of Osteoporosis. This year is hosted in London. While I will not be flying out there, I’m hoping to get recordings of the presentations like I did last year.
To ease your mind a bit about fractures after Prolia, here is a link to the study that I describe in my Prolia presentation https://asbmr.onlinelibrary.wiley.com/doi/full/10.1002/jbmr.4335 . Dr. Serge Ferrari presented slides from this study at the 9th Central European Congress of Osteoporosis. It shows how breaks are very prevalent for patients without bisphosphonate treatment after Prolia, but it also shows how infrequent breaks were when bisphosphonates are used. See figure 5. I think you are going to be just fine on alendronate.
Your hip will likely still be in the osteoporosis range even after a year of Alendronate. Perhaps after a year, you could switch to one of the osteoanabolics to build some structure with the BMD then switch back to alendronate.
Good luck!
Here is Figure 5 from the study I mention above.
Hi Windy,
Sorry for the confusion. I started my first treatment with Evenity. My spine T-Score went from -3.7 to about -3.4, which is not near the trial averages, but I still have hypercalciuria and have yet to figure out a way to get it down to a reasonable level. So being at -3.4, a bisphosphonate had no chance of getting me into a safe zone of about -2.0, so Prolia was my best option, which is what I'm on now and will likely be on for 10 years.
Mike